文献速递腹部介入CT

锥形束CT评估可切除及交界可切除胰腺肿瘤植入基准标记的分次内运动与分次间位置变化

Assessment with cone-beam computed tomography of intrafractional motion and interfractional position changes of resectable and borderline resectable pancreatic tumours with implanted fiducial marker.
PubMed 文献 · Br J Radiol · 2017-03-03

对23例胰腺癌患者,比较四维CT与锥形束CT间植入基准标记的运动幅度与平均位置差异,并模拟无动作水平(NAL)及扩展无动作水平(eNAL)方案后的残余不确定性。未校正时各方向所需外扩边界较大,eNAL可补偿分次间系统位置变化并获得最小边界。

要点

  • 胰腺肿瘤模拟定位时的运动幅度与位置常不能代表治疗时的情况。
  • 未校正时超上-下方向所需外扩边界最大,达24.8 mm。
  • eNAL方案可补偿分次间系统位置变化,获得最小外扩边界。

核心结论

  • 胰腺肿瘤模拟定位时的运动幅度与位置常不能代表治疗时的情况;eNAL补偿了分次间系统位置变化,可能是提高靶区准确性的实用方法。

研究设计与样本

  • 对23例患者,测量四维CT与锥形束CT之间植入基准标记的运动幅度(MMM)和平均标记位置(MMP)差异,并模拟采用无动作水平(NAL)和扩展无动作水平(eNAL)方案后的残余不确定性。

诊断标准与关键数值

  • 未校正时MMM的第95百分位数在左右方向为4.5 mm、前后方向为6.2 mm、超上-下方向为16.0 mm。
  • 未校正时MMP的系统(随机)误差在左右方向为2.8 mm(3.3 mm)、前后方向为3.2 mm(2.0 mm)、超上-下方向为5.9 mm(4.0 mm)。
  • 未校正时所需外扩边界为左右方向10.5 mm、前后方向11.7 mm、超上-下方向24.8 mm。
  • NAL减小了MMP的系统误差,但所得边界仍较大:左右方向8.0 mm、前后方向9.6 mm、超上-下方向18.1 mm。
  • eNAL补偿了时间趋势并获得最小边界:左右方向6.7 mm、前后方向6.7 mm、超上-下方向15.2 mm。

临床应用与阅片要点

  • 作者认为eNAL补偿了分次间系统位置变化,可能是提高靶区准确性的实用方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The volume of targets to which a high radiation dose can be delivered is limited for pancreatic radiotherapy. We assessed changes in movements of pancreatic tumours between simulation and treatment and determined compensatory margins.

METHODS: For 23 patients, differences in implanted fiducial marker motion magnitude (MMM) and mean marker position (MMP) between four-dimensional CT and cone-beam CT were measured. Subsequently, residual uncertainty was simulated after no action level (NAL) and extended no action level (eNAL) protocols were adopted.

RESULTS: With no correction, respective 95th percentile of MMM were 4.5 mm, 6.2 mm and 16.0 mm and systematic (random) errors of MMP were 2.8 mm (3.3 mm), 3.2 mm (2.0 mm) and 5.9 mm (4.0 mm) in the left-right (L-R), anteroposterior (A-P) and superoinferior (S-I) directions, so that large margins were required (L-R, 10.5 mm; A-P, 11.7 mm; and S-I, 24.8 mm). NAL reduced systematic errors of MMP, but resultant margins remained large (L-R, 8.0 mm; A-P, 9.6 mm; and S-I, 18.1 mm). eNAL compensated for time trends and obtained minimal margins (L-R, 6.7 mm; A-P, 6.7 mm; and S-I, 15.2 mm).

CONCLUSION: Motion magnitude and position of pancreatic tumours during simulation are frequently not representative of that during treatment. eNAL compensated for systematic interfractional position change and would be a practical approach for improving targeting accuracy. Advances in knowledge: Considerably large margins, especially in the S-I direction, were required to compensate for intrafractional motion and interfractional position changes of the pancreatic tumour. An application of eNAL was an effective strategy to diminish these margins.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Ohira S, Isono M, Ueda Y, et al. Assessment with cone-beam computed tomography of intrafractional motion and interfractional position changes of resectable and borderline resectable pancreatic tumours with implanted fiducial marker. Br J Radiol. 2017. PMID: 28256908. doi:10.1259/bjr.20160815

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。